Literature DB >> 9598675

The prevalence of multiple sclerosis in the Leeds Health Authority.

H L Ford1, E Gerry, C M Airey, A Vail, M H Johnson, D R Williams.   

Abstract

OBJECTIVES: To determine the prevalence of multiple sclerosis in the Leeds Health District.
METHODS: Multiple sources of case ascertainment were used-namely, neurology departments, hospital episode statistics, general practitioners, the Leeds branch of the Multiple Sclerosis Society, the West Yorkshire Multiple Sclerosis Therapy Centre, community physiotherapists and occupational therapists, the Leeds Wheelchair Centre, and the Young Disabled Unit. Data collection was from retrospective analysis of hospital and primary care case records. A population based incidence register was established by prospectively registering all new patients with diagnoses of multiple sclerosis.
RESULTS: On prevalence day, 30 April 1996, 712 people with multiple sclerosis were identified living in Leeds (population 732,061), giving a prevalence of 97/10(5). The prevalence for definite and probable multiple sclerosis was 84/10(5), and for suspected multiple sclerosis it was 13/10(5). The sex ratio of prevalent people with multiple sclerosis was 2.79 to 1 women to men. The mean age of prevalent cases was 51 years, the mean age at symptom onset was 34 years, and the mean duration of disease was 16 years. Forty cases were prospectively reported as incident cases from 1 November 1995 to 1 February 1996.
CONCLUSIONS: The prevalence of multiple sclerosis in Leeds was found to be similar to that in the south of the United Kingdom but lower than that in Scotland. There is no evidence of a latitudinal gradient of increasing prevalence of multiple sclerosis from the south to the north of England.

Entities:  

Mesh:

Year:  1998        PMID: 9598675      PMCID: PMC2170076          DOI: 10.1136/jnnp.64.5.605

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

1.  The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority.

Authors:  M H Roberts; J P Martin; D L McLellan; S A McIntosh-Michaelis; A J Spackman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

2.  Mortality rates from multiple sclerosis: geographical and temporal variations revisited.

Authors:  E S Williams; D R Jones; R O McKeran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

3.  Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies.

Authors:  M Elian; S Nightingale; G Dean
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

4.  The geographic distribution of multiple sclerosis and its estimated prevalence in the United States.

Authors:  C C LIMBURG
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

5.  Prevalence of multiple sclerosis in a south London borough.

Authors:  E S Williams; R O McKeran
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

6.  The prevalence of multiple sclerosis in south east Wales.

Authors:  R J Swingler; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

7.  The distribution of multiple sclerosis in the United Kingdom.

Authors:  R J Swingler; D Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

8.  A further prevalence study of multiple sclerosis in north-east Scotland.

Authors:  D I Shepherd; A W Downie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

9.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

10.  The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands.

Authors:  G Dean; J Goodall; A Downie
Journal:  J Epidemiol Community Health       Date:  1981-06       Impact factor: 3.710

View more
  10 in total

Review 1.  Development and importance of health needs assessment.

Authors:  J Wright; R Williams; J R Wilkinson
Journal:  BMJ       Date:  1998-04-25

2.  An assessment of the feasibility and utility of the MS symptom and impact diary (MSSID).

Authors:  Joanne Greenhalgh
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

3.  Multiple sclerosis: relapses, resource use, and costs.

Authors:  A J Hawton; C Green
Journal:  Eur J Health Econ       Date:  2015-10-05

4.  Prevalence of multiple sclerosis in the L'Aquila district, central Italy.

Authors:  R Totaro; C Marini; A Cialfi; M Giunta; A Carolei
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

5.  The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.

Authors:  C M Fox; S Bensa; I Bray; J P Zajicek
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

6.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

Review 7.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

8.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

9.  Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.

Authors:  Ali Manouchehrinia; Christopher R Tench; Jonathan Maxted; Rashid H Bibani; John Britton; Cris S Constantinescu
Journal:  Brain       Date:  2013-06-11       Impact factor: 13.501

10.  Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis.

Authors:  Jessica L Lynch; Nathan J Gallus; Marna E Ericson; Alvin J Beitz
Journal:  Pain       Date:  2007-09-04       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.